Beatrice Garrone

This inventor holds 9 USPTO granted patents, plus 5 CIPO patents and 7 EPO patents. Top assignee: Aziende Chimiche Riunite Angelini Francesco A.c.r.a.f. S.p.a.. Active years: 2011-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Beatrice Garrone. Retrieved from https://idiyas.com/inventor/beatrice-garrone

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9

% Patents Active = 22.2

CIPO Patents = 5

EPO Patents = 7 (Patent Applications = 6)

Average Co-Inventor Count = 5.1

ph-index = 2

Forward Citations = 26(Granted Patents)

Location History:

Morsasco, IT (2011)
Rome, IT (2011 - 2023)

Company Filing History:

9 out of 106

Aziende Chimiche Riunite Angelini Francesco A.c.r.a.f. S.p.a.

patents

Years Active: 2011-2023

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11752147 - Pharmaceutical composition for the treatment of pain (2023-09-12),

2. 10786498 - Combination of trazodone and gabapentin for the treatment of pain (2020-09-29),

3. 9655906 - Tricyclic indazole compound, method of preparation and pharmaceutical composition containing it (2017-05-23),

4. 9492542 - Pharmaceutical composition for the treatment of MCP-1 mediated inflammatory diseases (2016-11-15),

5. 9120801 - Tricyclic indazole compound, method of preparation and pharmaceutical composition containing it (2015-09-01),

6. 8871948 - (Aza)indole derivative substituted in position 5, pharmaceutical composition comprising it, intermediate compounds and preparation process therefor (2014-10-28),

7. 8399477 - (Aza)indole derivative substituted in position 5, pharmaceutical composition comprising it, intermediate compounds and preparation process therefor (2013-03-19),

8. 8017644 - 2-arylindole derivatives as nPGES-1 inhibitors (2011-09-13),

9. 7879836 - Pharmaceutical composition comprising a 1-(3-chlorophenyl)-3-alkylpiperazine for treating appetite disorder (2011-02-01),

Title: The Innovative Contributions of Beatrice Garrone in Pharmaceutical Research

Introduction: Beatrice Garrone, a prominent inventor based in Rome, Italy, has made significant strides in the pharmaceutical industry with her innovative work. With a robust portfolio of nine patents, Garrone stands out for her contributions to developing compositions aimed at alleviating pain.

Latest Patents: Among her latest inventions, Beatrice Garrone has developed a pharmaceutical composition for the treatment of pain. This invention involves a unique combination of trazodone or its salt and gabapentin or a salt or prodrug thereof. This synergistic combination demonstrates enhanced efficacy in pain management, showcasing Garrone's commitment to advancing therapeutic options for patients.

Career Highlights: Beatrice Garrone has a distinguished career, having worked with notable companies such as Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.p.A. Her experience in these esteemed institutions has provided her with a platform to innovate and develop her groundbreaking research in pharmaceuticals.

Collaborations: Throughout her career, Garrone has collaborated with esteemed colleagues, including Guido Furlotti and Nicola Cazzolla. These collaborations have facilitated a wealth of knowledge sharing, leading to significant advancements in their collective research efforts.

Conclusion: Beatrice Garrone's contributions to the field of pharmaceutical research highlight her innovative spirit and dedication to improving pain management. With nine patents to her name and a successful collaborative history, Garrone continues to inspire future generations of inventors and researchers in the critical realm of healthcare.

Profile summary based on public USPTO records.